ITNS (Itonis) EV-to-EBIT: -0.39 (As of Aug. 31, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Itonis EV-to-EBIT?

Itonis ITNS EV-to-EBIT is -0.39 as of Aug. 31, 2026.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Itonis's Enterprise Value is $0.61 Mil. Itonis's EBIT for the trailing twelve months (TTM) ended in Feb. 2008 was $-1.55 Mil. Therefore, Itonis's EV-to-EBIT for today is -0.39.

The historical rank and industry rank for Itonis's EV-to-EBIT or its related term are showing as below:

ITNS's EV-to-EBIT is not ranked *
in the Medical Distribution industry.
Industry Median: 11.49
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Itonis's Enterprise Value for the quarter that ended in Feb. 2008 was $3.74 Mil. Itonis's EBIT for the trailing twelve months (TTM) ended in Feb. 2008 was $-1.55 Mil. Itonis's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Feb. 2008 was -41.54%.

Itonis  (OTCPK:ITNS) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Itonis's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Feb. 2008 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Feb. 2008 ) =EBIT / Enterprise Value (Q: Feb. 2008 )
=-1.554/3.74083
=-41.54 %

Itonis's Enterprise Value for the quarter that ended in Feb. 2008 was $3.74 Mil.
Itonis's EBIT for the trailing twelve months (TTM) ended in Feb. 2008 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.55 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Itonis EV-to-EBIT Related Terms

Itonis EV-to-EBIT Historical Data

* Premium members only.

The historical data trend for Itonis's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Itonis EV-to-EBIT Chart

Itonis Annual Data
Trend Nov05 Nov06 Nov07
EV-to-EBIT
0.00 0.00 -11.59

Itonis Quarterly Data
Nov05 Feb06 May06 Aug06 Nov06 Feb07 May07 Aug07 Nov07 Feb08
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ITNS vs FZMD, SNYR, SGMFF: EV-to-EBIT Comparison

For the Medical Distribution subindustry, Itonis's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Itonis EV-to-EBIT vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Itonis's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Itonis's EV-to-EBIT falls into.


Itonis EV-to-EBIT Calculation

Itonis's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=0.609/-1.554
=-0.39

Itonis's current Enterprise Value is $0.61 Mil.
Itonis's EBIT for the trailing twelve months (TTM) ended in Feb. 2008 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.55 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EV-to-EBIT →
What does a EV-to-EBIT of -0.39 mean?
Itonis (ITNS) has a EV-to-EBIT of -0.39 as of Aug. 31, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Itonis and its competitors.
Is Itonis' EV-to-EBIT too high?
Itonis' current EV-to-EBIT is -0.39.
How does Itonis' EV-to-EBIT compare to FZMD and SNYR?
Itonis' EV-to-EBIT of -0.39 can be compared against companies in the Medical Distribution industry. The industry median EV-to-EBIT is 11.49. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Distribution company?
The median EV-to-EBIT among Medical Distribution companies is 11.49, based on 98 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Itonis and its competitors. For the Medical Distribution industry, the median EV-to-EBIT is 11.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Itonis's current EV-to-EBIT is -0.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Itonis stock overvalued right now?
Itonis (ITNS) has a current EV-to-EBIT of -0.39. The current EV-to-EBIT is -0.39. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Itonis (ITNS), the current EV-to-EBIT is -0.39 as of Aug. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Itonis Business Description

Address 25422 Trabuco Road, Suite 105-297, Lake Forest, CA, USA, 92630
Itonis Inc is a development-stage company. It operates as a holding company, which engages in the development and distribution of products to the medical and pharmaceutical industry. It is presently focused on marketing its Emesyl homeopathic anti-nausea product for retail sale. It produces and markets over-the-counter and prescription homeopathic preparations to treat both common ailments and chronic diseases.